TABLE 3.

Systemic adverse events experienced in the 5-day observation period following immunization of pediatric CF patients with the virosome or subunit influenza vaccine

Vaccine	Dose (ml)	Group (no. of subjects)	Mean age of subjects (yr)	Total no. (%) of vaccinees with at least one adverse event	% of vaccines with:
					Headache	Fatigue	Nausea	Cough	Coryza	Vertigo	Irritability	Othersa
Inflexal Berna V	0.5, once	A1 (4)	4.1	4	0	50	25	75	25	0	0	75
	0.5, once	A2 (15)	14.5	14 (93)	53	60	6.7	53	47	6.7	13	33
	0.25, twice	B1 (5)	3.8	5	0	20	20	40	80	0	20	20
	0.25, twice	B2 (19)	16.4	13 (68)	37	42	21	37	37	16	16	16
Influvac	0.25, twice	C (2)	2.9	2	0	100	0	100	100	0	0	0
	0.5, once	D (19)	15.7	13 (68)	32	47	5.3	47	26	11	21	26

^aInsomnia, vomiting, rigors, pharyngitis, thirst, apathy, abdominal pain, palpitation, laryngitis, increased sweating, euphoria, and earache.